Description | PE anti-human HLA-DR. HLA-DR is a heterodimeric cell surface glycoprotein comprised of a 36 kD α (heavy) chain and a 27 kD β (light) chain. It is expressed on B cells, activated T cells, monocytes/macrophages, dendritic cells, and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 molecules, HLA-DR is critical for efficient peptide presentation to CD4 T cells. |
Product Specific References | PubMed: 24733846, 20644118, 20538595, 24416448, 26181363, 27068708, 29207015, 29799520, 30173916, 28877459, 28755839, 31545472, 31364743, 31420544, 31150624, 30173916, 28877459, 29858049, 30796203, 31736948, 31908851, 30228352, 32884023, 33091337, 32937740, 32456524, 31486697, 33498319, 33790912, 33904395, 33450188, 33789089 |